Merck to submit its experimental COVID-19 oral treatment for emergency use authorization

Pharmaceutical company Merck says its experimental pill significantly reduces the effects of COVID-19 and plans to submit its findings to the Food and Drug Administration for emergency use authorization. CBS News researcher Max Bayer speaks with CBSN's Tanya Rivero about how this drug differs from those already in use.

from Home - CBSNews.com https://ift.tt/3kXO7v8